116 Collagenase Clostridium Histolyticum is a Cost-effective Treatment for Peyronie's Disease in Appropriately Selected Patients

K. Wymer; M. Ziegelmann; L. Trost

首页> 外文期刊>The journal of sexual medicine >116 Collagenase Clostridium Histolyticum is a Cost-effective Treatment for Peyronie's Disease in Appropriately Selected Patients

【24h】

116 Collagenase Clostridium Histolyticum is a Cost-effective Treatment for Peyronie's Disease in Appropriately Selected Patients

机译：116 Collagenase Clostridium Histolyticum is a Cost-effective Treatment for Peyronie's Disease in Appropriately Selected Patients

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The journal of sexual medicine》 |2018年第2期|共1页
作者
K. Wymer; M. Ziegelmann; L. Trost;
展开▼
作者单位

Mayo Clinic;

Mayo Clinic;

Mayo Clinic;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类性卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Surgical treatment of Peyronie's disease: choosing the best approach to improve patient satisfaction [J] . Paulo H. Egydio 亚洲男性学杂志（英文版） . 2008,第001期
2. Surgical treatment of Peyronie＇s disease： choosing the best approach to improve patient satisfaction [J] . Paulo H. Egydio 亚洲男性学杂志：英文版 . 2008,第001期
3. 116 Collagenase Clostridium Histolyticum is a Cost-effective Treatment for Peyronie's Disease in Appropriately Selected Patients [J] . K. Wymer, M. Ziegelmann, L. Trost The journal of sexual medicine . 2018,第2期

机译：116 Collagenase Clostridium Histolyticum is a Cost-effective Treatment for Peyronie's Disease in Appropriately Selected Patients
4. ULTRASOUND PREDICTIVE FACTORS FOR EFFICACY AND SAFETY OF THE USE OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (CCH) IN THE TREATMENT OF PEYRONIE'S DISEASE (PD): IMPACT OF PATIENT'S SELECTION [J] . Fernandez-Pascual E., Martinez-Salamanca J. I, Cerezo E., The journal of sexual medicine . 2018,第7Suppla3期

机译：胶原酶梭菌组织术（CCH）治疗Peyronie病（Pd）的疗效和安全性的超声预测因素：患者选择的影响
5. ULTRASOUND PREDICTIVE FACTORS FOR EFFICACY AND SAFETY OF THE USE OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (CCH) IN THE TREATMENT OF PEYRONIE'S DISEASE (PD): IMPACT OF PATIENT'S SELECTION [J] . Fernandez-Pascual E., Martinez-Salamanca J. I, Cerezo E., The journal of sexual medicine . 2018,第7Suppla3期

机译：胶原酶梭菌组织术（CCH）治疗Peyronie病（Pd）的疗效和安全性的超声预测因素：患者选择的影响
6. Novel Peptide-based Antimicrobial Agents for the Treatment of Clostridium Difficile Associated Disease [C] . David A. Kennedy, Marc Devocelle American Peptide Symposium . 2009

机译：基于新型肽的抗微生物剂，用于治疗梭菌差异相关疾病
7. The Comparison of Prescriptions Dispensed For Methadone Maintenance Patients to Non-Methadone Maintenance Patients for the Treatment of Chronic Diseases using PharmaNet Data [D] . Maruyama, Anna. 2012

机译：使用PharmaNet数据比较美沙酮维持治疗患者和非美沙酮维持治疗患者治疗慢性疾病的处方比较
8. Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives [O] . Paige K Kuhlmann, Kenneth J DeLay, James Anaissie, 2017

机译：胶原酶溶组织梭状芽胞杆菌治疗佩罗尼氏病：患者选择和观点
9. Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum: Male Patients and Their Female Partners [O] . Irwin Goldstein, MD, L. Dean Knoll, MD, Larry I. Lipshultz, MD, 2017

机译：溶组织酶梭状芽孢杆菌治疗后阴道神经病变的影响：男性患者及其女性伴侣

116 Collagenase Clostridium Histolyticum is a Cost-effective Treatment for Peyronie's Disease in Appropriately Selected Patients

著录项

相似文献

相关主题

期刊订阅